$CYH
COMMUNITY HEALTH SYSTEMS INC

2024 Q2 Form 10-Q Financial Statement

#000095017024048396 Filed on April 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $3.140B $3.140B
YoY Change 0.8% 1.03%
Cost Of Revenue $483.0M $487.0M
YoY Change -4.17% -3.94%
Gross Profit $2.657B $2.653B
YoY Change 1.76% 2.0%
Gross Profit Margin 84.62% 84.49%
Selling, General & Admin $1.402B $1.445B
YoY Change -1.13% -0.07%
% of Gross Profit 52.77% 54.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $126.0M $115.0M
YoY Change 2.44% -12.88%
% of Gross Profit 4.74% 4.33%
Operating Expenses $2.409B $2.405B
YoY Change 1.3% -0.33%
Operating Profit $238.0M $248.0M
YoY Change 2.15% 18.1%
Interest Expense -$216.0M -$209.0M
YoY Change 4.85% 0.97%
% of Operating Profit -90.76% -84.27%
Other Income/Expense, Net
YoY Change
Pretax Income $50.00M $22.00M
YoY Change 25.0% 266.67%
Income Tax $24.00M $28.00M
% Of Pretax Income 48.0% 127.27%
Net Earnings -$13.00M -$41.00M
YoY Change -65.79% -19.61%
Net Earnings / Revenue -0.41% -1.31%
Basic Earnings Per Share -$0.10 -$0.32
Diluted Earnings Per Share -$0.10 -$0.31
COMMON SHARES
Basic Shares Outstanding 139.0M 136.7M
Diluted Shares Outstanding 132.3M 131.3M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $39.00M $48.00M
YoY Change -66.95% -66.67%
Cash & Equivalents $39.00M $48.00M
Short-Term Investments
Other Short-Term Assets $292.0M $473.0M
YoY Change -49.13% 108.37%
Inventory $337.0M $329.0M
Prepaid Expenses
Receivables $2.195B $2.194B
Other Receivables $0.00 $131.0M
Total Short-Term Assets $3.199B $3.175B
YoY Change 0.22% 1.96%
LONG-TERM ASSETS
Property, Plant & Equipment $5.222B $5.861B
YoY Change -12.16% 11.53%
Goodwill $3.972B $3.957B
YoY Change -2.02% -3.49%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.989B $1.424B
YoY Change 36.51% -33.89%
Total Long-Term Assets $11.21B $11.24B
YoY Change -2.13% -2.32%
TOTAL ASSETS
Total Short-Term Assets $3.199B $3.175B
Total Long-Term Assets $11.21B $11.24B
Total Assets $14.41B $14.42B
YoY Change -1.62% -1.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $896.0M $941.0M
YoY Change 21.74% 32.16%
Accrued Expenses $1.249B $1.087B
YoY Change 4.17% -13.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $27.00M $34.00M
YoY Change -10.0% -12.82%
Total Short-Term Liabilities $2.172B $2.136B
YoY Change 4.62% 0.19%
LONG-TERM LIABILITIES
Long-Term Debt $11.50B $11.53B
YoY Change -1.91% -1.39%
Other Long-Term Liabilities $721.0M $1.272B
YoY Change -44.62% 96.6%
Total Long-Term Liabilities $12.23B $12.81B
YoY Change -6.18% 3.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.172B $2.136B
Total Long-Term Liabilities $12.23B $12.81B
Total Liabilities $15.29B $15.85B
YoY Change -5.25% 2.8%
SHAREHOLDERS EQUITY
Retained Earnings -$3.619B -$3.605B
YoY Change 2.81% 3.53%
Common Stock $2.191B $2.193B
YoY Change 6.88% 6.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.441B -$1.428B
YoY Change
Total Liabilities & Shareholders Equity $14.41B $14.42B
YoY Change -1.62% -1.41%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$13.00M -$41.00M
YoY Change -65.79% -19.61%
Depreciation, Depletion And Amortization $126.0M $115.0M
YoY Change 2.44% -12.88%
Cash From Operating Activities $101.0M $96.00M
YoY Change 17.44% 1820.0%
INVESTING ACTIVITIES
Capital Expenditures $88.00M $93.00M
YoY Change -16.19% -23.77%
Acquisitions $1.000M
YoY Change -87.5%
Other Investing Activities -$20.00M -$6.000M
YoY Change -205.26% -137.5%
Cash From Investing Activities -$108.0M -$99.00M
YoY Change 25.58% 421.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $885.0M
YoY Change 16.91%
Cash From Financing Activities -2.000M 13.00M
YoY Change -92.31% -67.5%
NET CHANGE
Cash From Operating Activities 101.0M 96.00M
Cash From Investing Activities -108.0M -99.00M
Cash From Financing Activities -2.000M 13.00M
Net Change In Cash -9.000M 10.00M
YoY Change -65.38% -61.54%
FREE CASH FLOW
Cash From Operating Activities $101.0M $96.00M
Capital Expenditures $88.00M $93.00M
Free Cash Flow $13.00M $3.000M
YoY Change -168.42% -102.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001108109
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 cyh Number Of Hospitals Sold
NumberOfHospitalsSold
1
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2024Q1 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2023Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2023Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtNoncurrent
CY2024Q1 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtNoncurrent
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-15925
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
COMMUNITY HEALTH SYSTEMS, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3893191
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4000 Meridian Boulevard
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Franklin
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37067
CY2024Q1 dei City Area Code
CityAreaCode
615
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
465-7000
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, $.01 par value
CY2024Q1 dei Trading Symbol
TradingSymbol
CYH
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
138966388
CY2024Q1 us-gaap Revenues
Revenues
3140000000
CY2023Q1 us-gaap Revenues
Revenues
3108000000
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1368000000
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1365000000
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
487000000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
507000000
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
845000000
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
835000000
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
77000000
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
81000000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
115000000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
132000000
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
17000000
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
-22000000
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
2909000000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
2898000000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
231000000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
210000000
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-211000000
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-207000000
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2000000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3000000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22000000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6000000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-6000000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-20000000
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
35000000
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
31000000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-41000000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-51000000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.4
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.32
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.4
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131272044
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129688917
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131272044
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
129688917
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-6000000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-20000000
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-2000000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3000000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3000000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-8000000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-17000000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
35000000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
31000000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43000000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-48000000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48000000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38000000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2194000000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2231000000
CY2024Q1 us-gaap Supplies
Supplies
329000000
CY2023Q4 us-gaap Supplies
Supplies
328000000
CY2024Q1 us-gaap Prepaid Taxes
PrepaidTaxes
34000000
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
76000000
CY2024Q1 cyh Prepaid Expenses And Taxes
PrepaidExpensesAndTaxes
263000000
CY2023Q4 cyh Prepaid Expenses And Taxes
PrepaidExpensesAndTaxes
260000000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
307000000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
275000000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
3175000000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3208000000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9607000000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9511000000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4388000000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4304000000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5219000000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5207000000
CY2024Q1 us-gaap Goodwill
Goodwill
3957000000
CY2023Q4 us-gaap Goodwill
Goodwill
3958000000
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
29000000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
29000000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2037000000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2053000000
CY2024Q1 us-gaap Assets
Assets
14417000000
CY2023Q4 us-gaap Assets
Assets
14455000000
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
34000000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
21000000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
115000000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
124000000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
941000000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
912000000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
504000000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
571000000
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
207000000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
160000000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
335000000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
354000000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2136000000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2142000000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11533000000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11466000000
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
354000000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
369000000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
546000000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
563000000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
726000000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
739000000
CY2024Q1 us-gaap Liabilities
Liabilities
15295000000
CY2023Q4 us-gaap Liabilities
Liabilities
15279000000
CY2024Q1 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
329000000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
323000000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
138966388
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
138966388
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
136774911
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
136774911
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
1000000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2192000000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2185000000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16000000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14000000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3605000000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3564000000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1428000000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1392000000
CY2024Q1 us-gaap Minority Interest
MinorityInterest
221000000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
245000000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1207000000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1147000000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14417000000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14455000000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-6000000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-20000000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
115000000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
132000000
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-14000000
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
7000000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6000000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6000000
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
17000000
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
-22000000
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-33000000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-42000000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-39000000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2000000
CY2024Q1 cyh Increase Decrease In Supplies Prepaid Expenses And Other Current Assets
IncreaseDecreaseInSuppliesPrepaidExpensesAndOtherCurrentAssets
40000000
CY2023Q1 cyh Increase Decrease In Supplies Prepaid Expenses And Other Current Assets
IncreaseDecreaseInSuppliesPrepaidExpensesAndOtherCurrentAssets
50000000
CY2024Q1 cyh Increase Decrease In Accounts Payable Accrued Liabilities And Income Taxes
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndIncomeTaxes
-13000000
CY2023Q1 cyh Increase Decrease In Accounts Payable Accrued Liabilities And Income Taxes
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndIncomeTaxes
-32000000
CY2024Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
41000000
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
56000000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
96000000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5000000
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1000000
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
8000000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
93000000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
122000000
CY2023Q1 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
92000000
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000000
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5000000
CY2024Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
4000000
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
26000000
CY2024Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
12000000
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
61000000
CY2024Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
4000000
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
5000000
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
10000000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
16000000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-99000000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19000000
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2000000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4000000
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
2000000
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
1000000
CY2024Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
50000000
CY2023Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
44000000
CY2024Q1 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
17000000
CY2023Q1 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
29000000
CY2024Q1 us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
933000000
CY2023Q1 us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
815000000
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
885000000
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
757000000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13000000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40000000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10000000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
26000000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38000000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118000000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48000000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
144000000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
149000000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
197000000
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
CY2024Q1 cyh Corporate Office Costs
CorporateOfficeCosts
82000000
CY2023Q1 cyh Corporate Office Costs
CorporateOfficeCosts
61000000
CY2024Q1 us-gaap Revenues
Revenues
3140000000
CY2023Q1 us-gaap Revenues
Revenues
3108000000
CY2024Q1 cyh Amounts Due To Third Party Payors
AmountsDueToThirdPartyPayors
74000000
CY2023Q4 cyh Amounts Due To Third Party Payors
AmountsDueToThirdPartyPayors
97000000
CY2024Q1 cyh Amounts Due From Third Party Payors
AmountsDueFromThirdPartyPayors
131000000
CY2023Q4 cyh Amounts Due From Third Party Payors
AmountsDueFromThirdPartyPayors
130000000
CY2024Q1 us-gaap Charity Care Other Measurement Basis Amount
CharityCareOtherMeasurementBasisAmount
316000000
CY2023Q1 us-gaap Charity Care Other Measurement Basis Amount
CharityCareOtherMeasurementBasisAmount
326000000
CY2024Q1 us-gaap Charity Care Direct And Indirect Cost Basis Amount
CharityCareDirectAndIndirectCostBasisAmount
30000000
CY2023Q1 us-gaap Charity Care Direct And Indirect Cost Basis Amount
CharityCareDirectAndIndirectCostBasisAmount
38000000
CY2023Q1 cyh Amount Related To Several Assets Idled Disposed Or Held For Sale
AmountRelatedToSeveralAssetsIdledDisposedOrHeldForSale
3000000
CY2022Q4 us-gaap Change In Accounting Principle Accounting Standards Update Adopted
ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
true
CY2022Q4 us-gaap Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
true
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6000000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6000000
CY2024Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
-5000000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
-5000000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
34000000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P24M
CY2024Q1 cyh Employee Service Share Based Compensation Nonvested Awards Modifications To Awards
EmployeeServiceShareBasedCompensationNonvestedAwardsModificationsToAwards
0
CY2023Q1 cyh Employee Service Share Based Compensation Nonvested Awards Modifications To Awards
EmployeeServiceShareBasedCompensationNonvestedAwardsModificationsToAwards
0
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Other Current Assets
DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets
6000000
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Other Current Assets
DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets
6000000
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Other Noncurrent Assets
DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets
219000000
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Other Noncurrent Assets
DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets
218000000
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Accrued Liabilities Current
DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent
13000000
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Accrued Liabilities Current
DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent
13000000
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
6772000000
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
2814000000
CY2023Q4 us-gaap Goodwill
Goodwill
3958000000
CY2024Q1 cyh Goodwill Written Off Related To Divested Or Disposal Of Assets Held For Sale
GoodwillWrittenOffRelatedToDivestedOrDisposalOfAssetsHeldForSale
-1000000
CY2024Q1 us-gaap Goodwill Gross
GoodwillGross
6771000000
CY2024Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
2814000000
CY2024Q1 us-gaap Goodwill
Goodwill
3957000000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
3000000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000000
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.273
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
4.333
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-323000000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-338000000
CY2024Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
11567000000
CY2023Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
11487000000
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
34000000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
21000000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11533000000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11466000000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
149000000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
197000000
CY2024Q1 cyh Fair Value Assets Level1 To Level2 Transfer Amount
FairValueAssetsLevel1ToLevel2TransferAmount
0
CY2023Q1 cyh Fair Value Assets Level1 To Level2 Transfer Amount
FairValueAssetsLevel1ToLevel2TransferAmount
0
CY2024Q1 cyh Fair Value Assets Level2 To Level1 Transfer Amount
FairValueAssetsLevel2ToLevel1TransferAmount
0
CY2023Q1 cyh Fair Value Assets Level2 To Level1 Transfer Amount
FairValueAssetsLevel2ToLevel1TransferAmount
0
CY2024Q1 cyh Fair Value Liabilities Level1 To Level2 Transfer Amount
FairValueLiabilitiesLevel1ToLevel2TransferAmount
0
CY2023Q1 cyh Fair Value Liabilities Level1 To Level2 Transfer Amount
FairValueLiabilitiesLevel1ToLevel2TransferAmount
0
CY2024Q1 cyh Fair Value Liabilities Level2 To Level1 Transfer Amount
FairValueLiabilitiesLevel2ToLevel1TransferAmount
0
CY2023Q1 cyh Fair Value Liabilities Level2 To Level1 Transfer Amount
FairValueLiabilitiesLevel2ToLevel1TransferAmount
0
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
52000000
CY2024Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
3000000
CY2023Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
3000000
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1000000
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1000000
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
48000000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
55000000
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
23000000
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
22000000
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
7000000
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
5000000
CY2024Q1 us-gaap Sublease Income
SubleaseIncome
1000000
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
1000000
CY2024Q1 cyh Cost Of Operating Lease
CostOfOperatingLease
77000000
CY2023Q1 cyh Cost Of Operating Lease
CostOfOperatingLease
81000000
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3000000
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3000000
CY2024Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
3000000
CY2023Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
3000000
CY2024Q1 cyh Finance Lease Cost
FinanceLeaseCost
6000000
CY2023Q1 cyh Finance Lease Cost
FinanceLeaseCost
6000000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
642000000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
665000000
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2000000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2000000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
214000000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
214000000
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
46000000
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
1000000
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10000000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
24000000
CY2024Q1 cyh Capital Stock Authorized
CapitalStockAuthorized
400000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 cyh Amount Available For Dividend Distribution For Restrictions On Dividends Stock Repurchases
AmountAvailableForDividendDistributionForRestrictionsOnDividendsStockRepurchases
300000000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1147000000
CY2024Q1 cyh Comprehensive Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interests
ComprehensiveIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterests
-24000000
CY2024Q1 cyh Distributions To Noncontrolling Interests Net Of Contributions
DistributionsToNoncontrollingInterestsNetOfContributions
33000000
CY2024Q1 cyh Redeemable Noncontrolling Interest Change In Redemption Value
RedeemableNoncontrollingInterestChangeInRedemptionValue
3000000
CY2024Q1 cyh Adjustment To Additional Paid In Capital Cancellation Of Restricted Stock For Tax Withholdings On Vested Shares
AdjustmentToAdditionalPaidInCapitalCancellationOfRestrictedStockForTaxWithholdingsOnVestedShares
-2000000
CY2024Q1 cyh Other Reclassifications Of Noncontrolling Interests
OtherReclassificationsOfNoncontrollingInterests
-10000000
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6000000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1207000000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1275000000
CY2023Q1 cyh Comprehensive Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interests
ComprehensiveIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterests
-37000000
CY2023Q1 cyh Distributions To Noncontrolling Interests Net Of Contributions
DistributionsToNoncontrollingInterestsNetOfContributions
11000000
CY2023Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
1000000
CY2023Q1 cyh Redeemable Noncontrolling Interest Change In Redemption Value
RedeemableNoncontrollingInterestChangeInRedemptionValue
-32000000
CY2023Q1 cyh Adjustment To Additional Paid In Capital Cancellation Of Restricted Stock For Tax Withholdings On Vested Shares
AdjustmentToAdditionalPaidInCapitalCancellationOfRestrictedStockForTaxWithholdingsOnVestedShares
-4000000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6000000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1352000000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131272044
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129688917
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131272044
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
129688917
CY2024Q1 cyh Increase In Number Of Shares To Diluted Shares Calculation If Income From Continuing Operations Would Have Been Generated
IncreaseInNumberOfSharesToDilutedSharesCalculationIfIncomeFromContinuingOperationsWouldHaveBeenGenerated
443799
CY2023Q1 cyh Increase In Number Of Shares To Diluted Shares Calculation If Income From Continuing Operations Would Have Been Generated
IncreaseInNumberOfSharesToDilutedSharesCalculationIfIncomeFromContinuingOperationsWouldHaveBeenGenerated
468193
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5800333
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5889077
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-048396-index-headers.html Edgar Link pending
0000950170-24-048396-index.html Edgar Link pending
0000950170-24-048396.txt Edgar Link pending
0000950170-24-048396-xbrl.zip Edgar Link pending
cyh-20240331.htm Edgar Link pending
cyh-20240331.xsd Edgar Link pending
cyh-ex10_1.htm Edgar Link pending
cyh-ex10_2.htm Edgar Link pending
cyh-ex10_3.htm Edgar Link pending
cyh-ex31_1.htm Edgar Link pending
cyh-ex31_2.htm Edgar Link pending
cyh-ex32_1.htm Edgar Link pending
cyh-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img72841907_0.jpg Edgar Link pending
img73765428_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
cyh-20240331_htm.xml Edgar Link completed